Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Working Capital/Sales

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.593.173.513.833.34

What is the latest Working Capital/Sales ratio of BETA DRUGS ?

The latest Working Capital/Sales ratio of BETA DRUGS is 1.59 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.59
Mar20243.17
Mar20233.51
Mar20223.83
Mar20213.34

How is Working Capital/Sales of BETA DRUGS Trending?

Years Working Capital/Sales % Change
Mar2025 1.59
-49.84
Mar2024 3.17
-9.69
Mar2023 3.51
-8.36
Mar2022 3.83
14.67
Mar2021 3.34 -

Other Financial Ratios of BETA DRUGS


Compare Working Capital/Sales ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,351.5 Cr -0.3% -18.4% 9.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-0.3%

-18.4%

9.5%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses